v3.26.1
Consolidated statements of comprehensive income (loss) - USD ($)
 3 Months Ended 9 Months Ended
May 31, 2026
May 31, 2025
May 31, 2026
May 31, 2025
Consolidated statements of comprehensive income (loss)        
Revenues [note 20] $ 18,371,221 $ 210,708 $ 48,595,549 $ 387,927
Cost of sales [note 7] 15,182,924 185,498 36,811,445 402,831
Gross profit (loss) 3,188,297 25,210 11,784,104 (14,904)
Expenses        
Research and development 49,739 528,777 268,752 1,276,326
Selling and marketing expenses 2,154,069 740,666 5,600,296 1,891,794
Office salaries and benefits 2,340,352 512,525 7,471,800 1,538,915
Office and general [note 7] 2,489,407 321,127 5,513,846 925,587
Professional fees 630,275 499,256 1,895,695 1,937,474
Share-based compensation [note 19] 21,035 8,440 65,146 31,660
Depreciation and amortization 851,945 95,651 2,494,634 263,556
Net finance expense (income) [note 21] 369,484 2,435,885 387,472 948,432
Operating expense 8,906,306 5,142,327 23,697,641 8,813,744
Loss before tax (5,718,009) (5,117,117) (11,913,537) (8,828,648)
Income taxes        
Current tax expense (recovery) (6,281) 6,106 (8,143) 10,555
Deferred tax expense (recovery) 772 (7,468) (15,421) (3,413)
Total income tax expense (recovery) (5,509) (1,362) (23,564) 7,142
Net loss for the period (5,712,500) (5,115,755) (11,889,973) (8,835,790)
Items of comprehensive loss that will be subsequently reclassified to earnings:        
Foreign currency translation differences for foreign operations, net of tax (196,375) 750,467 (115,459) 333,933
Other comprehensive loss, net of tax (196,375) 750,467 (115,459) 333,933
Total comprehensive loss for the period, net of tax $ (5,908,875) $ (4,365,288) $ (12,005,432) $ (8,501,857)
Weighted average shares outstanding, Basic (in shares) 196,326 2,744 96,790 1,544
Basic income (loss) per share (in dollars per share) $ (29.1) $ (1,864.34) $ (122.84) $ (5,722.66)
Diluted income (loss) per share (in dollars per share) $ (29.1) $ (1,864.34) $ (122.84) $ (5,722.66)